Cardiac Myosin Inhibitors and HCM: Therapy of the (Near) Future

March 4, 2022

Robert Colbert Headshot
Robert Colbert, MD
Cardiology Fellow
University of Washington

Overview: 

Grand Rounds Learning Objectives

Upon completion of this program, attendees should be able to:

  • Understand the mechanism of cardiac myosin inhibitors
  • Know the results the recent trials for mavacamten
  • Become aware of future studies